ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Barrier proteins in tumors are possible key to immunotherapy success – Medical Xpress

Medical XpressBarrier proteins in tumors are possible key to immunotherapy successMedical XpressBy comparing variations in protein expression in tumor samples from a single melanoma patient, researchers from the Johns Hopkins Bloomberg~Kimmel …a… Continue reading

2017-06-28 Michael Zand NEWS

Hammered on a gene therapy setback, Dimension cuts staff and circles the wagons – Endpoints News

Endpoints NewsHammered on a gene therapy setback, Dimension cuts staff and circles the wagonsEndpoints NewsDimension Therapeutics is winnowing out 25% of its staff as it concentrates on three gene therapy programs, including one partnered with Bayer th… Continue reading

2017-06-28 Michael Zand NEWS

Trials show unique stem cells a potential asthma treatment – EurekAlert (press release)

Continue reading

2017-06-28 Michael Zand NEWS

U.S. Patent Office to Confirm Kite’s Seminal Eshhar CAR-T Patent … – PharmiWeb.com (press release)


EurekAlert (press release)

Trials show unique stem cells a potential asthma treatment
EurekAlert (press release)
The Monash Biomedicine Discovery Institute (BDI) scientists provided the experimental expertise to test Cynata Therapeutics’ induced pluripotent stem cell-derived mesenchymal stem cells (MSCs) in a model of experimental asthma. Induced pluripotent stem …

Continue reading

2017-06-28 Michael Zand NEWS

Arix leads $45M series B for gene therapy biotech LogicBio – FierceBiotech

FierceBiotechArix leads $45M series B for gene therapy biotech LogicBioFierceBiotechLogicBio Therapeutics has got off a $45 million series B funding round as it eyes the cash for disease-modifying gene therapies in rare childhood diseases. London-based… Continue reading

2017-06-28 Michael Zand NEWS

Barrier Proteins in Tumors are Possible Key to Immunotherapy Success – Newswise (press release)

U.S. Patent Office to Confirm Kite’s Seminal Eshhar CAR-T Patent …
PharmiWeb.com (press release)
Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that the United States Patent and Trademark Office (USPTO) has provided a …

and more »

Continue reading

2017-06-28 Michael Zand NEWS

US Patent Office to Confirm Kite’s Seminal Eshhar CAR-T Patent – Business Wire (press release)

Barrier Proteins in Tumors are Possible Key to Immunotherapy Success
Newswise (press release)
Newswise — By comparing variations in protein expression in tumor samples from a single melanoma patient, researchers from the Johns Hopkins Bloomberg~Kimmel Institute and the Memorial Sloan-Kettering Cancer Center say their findings have the …

Continue reading

2017-06-28 Michael Zand NEWS

First ‘haploid’ human stem cells could change the face of medical research – Medical Xpress

US Patent Office to Confirm Kite’s Seminal Eshhar CAR–T Patent
Business Wire (press release)
SANTA MONICA, Calif.–(BUSINESS WIRE)–Kite Pharma, Inc., (Nasdaq:KITE), a leading cell therapy company, today announced that the United States Patent and Trademark Office (USPTO) has provided a Notice of Intent to issue an Ex Parte Reexamination …

Continue reading

2017-06-28 Michael Zand NEWS
  • 1
  • …
  • 1,567
  • 1,568
  • 1,569
  • 1,570
  • 1,571
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Medical Xpress

First ‘haploid’ human stem cells could change the face of medical research
Medical Xpress
Haploid human embryonic stem cells. Credit: Azrieli Center for Stem Cells and Genetic Research at Hebrew University. Stem cell research holds huge potential for medicine and human health. In particular, human embryonic stem cells (ESCs), with their …

and more »